← FDA DRUG APPROVALS

FDA ANDA · ANDA088212

CYPROHEPTADINE HYDROCHLORIDE

Sponsor: CHARTWELL RX

APPLICATION
ANDA088212
TYPE
ANDA
ORIGINAL APPROVAL
1983-05-26
LATEST ACTION
2000-10-06
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

CYPROHEPTADINE HYDROCHLORIDEPrescription
CYPROHEPTADINE HYDROCHLORIDE 4MG · TABLET · ORAL

Approval history

2000-10-06Manufacturing (CMC) · Supplement 14AP
1997-05-12Labeling · Supplement 12AP
1991-03-04Labeling · Supplement 9AP
1989-11-20Labeling · Supplement 8AP
1989-10-10Manufacturing (CMC) · Supplement 6AP
1988-03-10Manufacturing (CMC) · Supplement 4AP
1983-11-16Manufacturing (CMC) · Supplement 1AP
1983-05-26OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →